Le Lézard
Classified in: Health, Business
Subject: PER

PCMA Names JC Scott New President and CEO


WASHINGTON, Sept. 20, 2018 /PRNewswire/ -- The Pharmaceutical Care Management Association (PCMA), the national trade association representing America's pharmacy benefit managers, has named JC Scott the association's next President and CEO, effective October 15. Scott is currently the Chief Advocacy Officer for the Advanced Medical Technology Association (AdvaMed).

(PRNewsfoto/Pharmaceutical Care Management)

"JC is an exceptional choice with a tremendous record of accomplishments, both in the regulatory sphere as well as legislatively," said PCMA Board Chairman Tim Wentworth of Express Scripts. "He has the policy depth and acumen in federal and state advocacy that will serve our association and industry well, and set us on new paths of success moving forward. On behalf of the board, I also want to thank Mark Merritt for his 15 years of exemplary service to our industry and organization and appreciate his willingness to help with the transition."

"I'm extremely excited about this opportunity to represent an industry that lowers costs, protects consumers, and delivers value for millions of Americans," said Scott. "PBMs are central to solving the health care challenges facing our nation and are ready to be partners in driving real solutions. I look forward to working with these companies to help improve access to affordable prescription drugs."

At AdvaMed, Scott led all external affairs activities for the association - coordinating the government affairs, grassroots, media relations, communications and alliance development components on behalf of the medical device and technology industry.

Prior to joining AdvaMed in 2011, Scott served as Senior Vice President of Federal Relations of the American Council of Life Insurers (ACLI). Scott has also served in various capacities in the House of Representatives, most recently as Deputy Director of Policy for the House Republican Conference. Scott also served as a Committee Associate with the Select Committee on Homeland Security, formed after September 11, 2001 and as Legislative Director for former-Representative Deborah Pryce of Ohio, among other positions. 

PCMA is the national association representing America's pharmacy benefit managers (PBMs). PBMs administer prescription drug plans for more than 266 million Americans who have health insurance from a variety of sponsors including: commercial health plans, self-insured employer plans, union plans, Medicare Part D plans, the Federal Employees Health Benefits Program (FEHBP), state government employee plans, Medicaid plans, and others.

 

SOURCE Pharmaceutical Care Management Association


These press releases may also interest you

at 11:04
Addressing the issue of employee wellness in healthcare, the American Association for Physician Leadership (AAPL) has published a new book, Working Happy! How to Survive Burnout and Find Your Work/Life Synergy in the Healthcare Industry. Author...

at 11:00
TDIndustries, a leading mechanical construction and facilities services firm, proudly announces that its Vice President of Environmental, Health and Safety Jamie Dabbs, CSP, ASP, CRIS, was named Construction Safety Professional of the Year by...

at 11:00
Nicklaus Children's Hospital this month attained Magnet recognition by the American Nurses Credentialing Center's Magnet Recognition Program® for the fifth consecutive term. Nicklaus Children's is one of only five children's hospitals in the nation...

at 10:45
The "PCR Markets. Forecasts for qPCR, dPCR, Singleplex & Multiplex Markets and by Application, Product and Place. With Executive and Consultant Guides, Including Customized Forecasting and Analysis. 2023 to 2027" report has been added to...

at 10:30
The "Licensing Deals in Biotechnology 2019-2024" report has been added to ResearchAndMarkets.com's offering. Licensing Deals in Biotechnology provides a detailed understanding and analysis of how and why companies enter licensing deals. Fully...

at 10:30
The "Molecular Diagnostics for Cancer: Markets Forecasts by Cancer Type, Product, and Place with Executive & Consultant Guides and Customization. 2023 to 2027" report has been added to ResearchAndMarkets.com's offering. Exciting technical...



News published on and distributed by: